Shanshan Liang

ORCID: 0000-0003-2752-1108 · 6 papers in corpus
other 2025
Preimplantation genetic testing for structural rearrangements by genome-wide SNP genotyping and haplotype analysis: a prospective multicenter clinical study
EBioMedicine ·doi:10.1016/j.ebiom.2024.105514

BACKGROUND: Preimplantation genetic testing for chromosomal structural rearrangements (PGT-SR) has been widely utilized to select euploid embryos in patients carrying balanced chromosomal rearrangements (BCRs) by chromosome copy number anal…

other 2024
Analyzing the impact of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) on the reproductive system using network toxicology and molecular docking
Heliyon ·doi:10.1016/j.heliyon.2024.e39419

Growing evidence suggests that perfluorinated compounds (PFCs) contribute to reproductive toxicity, with perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) being the most extensively studied. These chemicals are known to low…

observational 2022
The impact of different endometrial preparation protocols on obstetric and neonatal complications in frozen-thawed embryo transfer: a retrospective cohort study of 3,458 singleton deliveries
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-022-01009-x

BACKGROUND: Frozen-thawed embryo transfer (FET) is thought to be associated with obstetric and neonatal complications after in vitro fertilization/intracytoplasmic single sperm injection (IVF/ICSI) treatment. The study aimed to determine wh…

2007
A novel therapeutic agent for the treatment of endometriosis: 3-ethyl pyridine (3EP), detected from tobacco smoke – direct effects of a 3EP-loaded vaginal ring on deep and vaginal endometriosis
·doi:10.1016/j.fertnstert.2007.07.862
2006
Use Of Cabergoline, A Dopamine Agonist, Combined With Medroxyprogesterone Acetate In A Subgroup Of Patients With Endometrial Hyperplasia And Atypical Endometrial Hyperplasia
·doi:10.1136/ijgc-00009577-200610001-00249
2000
Effectiveness of long term GN‐RH agonist administration for treatment of endometriosis combined with estrogen‐progestogen add back therapy
·doi:10.1016/s0020-7292(00)82576-x